Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom F Lue

Showing results (11-20 of 281) with videos related to

Pageof 29
Sort By:
BJU International|July 27, 2005
Phosphodiesterase type 5 inhibitors for erectile dysfunctionCulley C Carson, Tom F Lue
Nature Clinical Practice. Urology|October 7, 2008
Stem cells in urology: how far have we come?Ching-Shwun Lin, Tom F Lue
The Journal of Urology|April 17, 2002
Correction of penile curvature using the 16-dot plication technique: a review of 132 patientsShahram S Gholami, Tom F Lue
The Journal of Urology|August 8, 2006
Neuromodulatory therapy to improve erectile function recovery outcomes after pelvic surgeryArthur L Burnett, Tom F Lue
European Urology|October 17, 2008
Editorial comment on: Apoptosis and effects of intracavernous bone marrow cell injection in a rat model of postprostatectomy erectile dysfunctionAlan W Shindel, Tom F Lue
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 19, 2009
Optimizing sexual function outcomes after radical prostatectomyAnthony J Bella, Tom F Lue
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 13, 2009
Colour duplex ultrasound and simplified corporoglanular shunting procedures with and without tunnelling in contemporary management of priapismAnthony J Bella, Tom F Lue
European Urology|September 15, 2007
Words of wisdom. Re: feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapismTom F Lue, Anthony J Bella
European Urology|November 15, 2012
Adipose-derived stem cells for the treatment of Peyronie's disease?Ching-Shwun Lin, Tom F Lue
Translational Andrology and Urology|January 28, 2016
Commentary on the myths of Peyronie's diseaseAlex K Wu, Tom F Lue
Pageof 29

Showing results (11-20 of 281) with videos related to

Sort By:
Pageof 29
BJU International|July 27, 2005
Phosphodiesterase type 5 inhibitors for erectile dysfunctionCulley C Carson, Tom F Lue
Nature Clinical Practice. Urology|October 7, 2008
Stem cells in urology: how far have we come?Ching-Shwun Lin, Tom F Lue
The Journal of Urology|April 17, 2002
Correction of penile curvature using the 16-dot plication technique: a review of 132 patientsShahram S Gholami, Tom F Lue
The Journal of Urology|August 8, 2006
Neuromodulatory therapy to improve erectile function recovery outcomes after pelvic surgeryArthur L Burnett, Tom F Lue
European Urology|October 17, 2008
Editorial comment on: Apoptosis and effects of intracavernous bone marrow cell injection in a rat model of postprostatectomy erectile dysfunctionAlan W Shindel, Tom F Lue
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 19, 2009
Optimizing sexual function outcomes after radical prostatectomyAnthony J Bella, Tom F Lue
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 13, 2009
Colour duplex ultrasound and simplified corporoglanular shunting procedures with and without tunnelling in contemporary management of priapismAnthony J Bella, Tom F Lue
European Urology|September 15, 2007
Words of wisdom. Re: feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapismTom F Lue, Anthony J Bella
European Urology|November 15, 2012
Adipose-derived stem cells for the treatment of Peyronie's disease?Ching-Shwun Lin, Tom F Lue
Translational Andrology and Urology|January 28, 2016
Commentary on the myths of Peyronie's diseaseAlex K Wu, Tom F Lue
Pageof 29